Pie chart icon


View performance benchmarks of the PTAB, including dispositions, pendency, inventory, and other tracking measures.


Trial Statistics

Appeal and Interference Statistics

Special Reports

Orange Book/Biologics Study (Jul. 2019) - a report on AIA trials involving petitions challenging Orange Book listed patents and biologic patents
     Data for Orange Book/Biologics Study (Sep. 2019) - data for the Orange Book/Biologics study

Parallel Proceedings Study (Apr. 2019) - a report on interaction between parallel proceedings at the USPTO (e.g., AIA proceedings, reexam, and resissue) involving issued patents

Motion to Amend Study, Installment 5 through FY2018 (updated Mar. 2019) - a report on the outcomes of motions to amend in AIA trials

Data for 326 Completed Trials (Mar. 2019) - a report on the data for the 326 completed trials with MTA

Expanded Panels Study (Mar. 2018) - a report on panel expansion in AIA trials

Orange Book-listed Patent Study (Mar. 2018) - a report on FDA-approved drug patents challenged in AIA trials

Multiple Petition Study (Oct. 2017) - a report on multiple petitions filed in AIA trials


Email questions about PTAB Statistics to PTAB Statistics Questions